Showing results (181-190 of 226) with videos related to
Sort By:
Pageof 23
Genome Medicine|February 26, 2021
ClinSV: clinical grade structural and copy number variant detection from whole genome sequencing dataAndre E Minoche, Ben Lundie, Greg B Peters, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2010
Comprehensive mapping of p53 pathway alterations reveals an apparent role for both SNP309 and MDM2 amplification in sarcomagenesisMoriko Ito, Louise Barys, Terence O'Reilly, et al.The Journal of Clinical Investigation|March 25, 2009
Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in miceMaya Kansara, Michael Tsang, Laurent Kodjabachian, et al.Blood Advances|April 14, 2022
Using whole-genome sequencing to characterize clinically significant blood groups among healthy older AustraliansSudhir Jadhao, Candice Davison, Eileen V Roulis, et al.European Journal of Cancer (Oxford, England : 1990)|October 11, 2023
Modified study designs to expand treatment options in personalised oncology: a multistakeholder viewChristophe Le Tourneau, Fabrice André, Åslaug Helland, et al.Eclinicalmedicine|April 28, 2025
Genetic predisposition in sarcomas: clinical implications and managementElizabeth A Connolly, Kjetil Boye, Sylvie Bonvalot, et al.Nature Medicine|April 20, 2022
Delivering precision oncology to patients with cancerJoaquin Mateo, Lotte Steuten, Philippe Aftimos, et al.The American Journal of Pathology|June 24, 2005
Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaBTeresa Morgan, Gerald J Atkins, Melanie K Trivett, et al.Molecular Oncology|November 25, 2022
Early circulating tumor DNA dynamics as a pan-tumor biomarker for long-term clinical outcome in patients treated with durvalumab and tremelimumabMaya Kansara, Neeru Bhardwaj, Subotheni Thavaneswaran, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2013
Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysisMarnie Collins, Miriam Wilhelm, Rachel Conyers, et al.Pageof 23